IDXX

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Wall Street analysts forecast IDXX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IDXX is 785.63 USD with a low forecast of 750.00 USD and a high forecast of 830.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

IDEXX Laboratories Inc revenue for the last quarter amounts to 1.11B USD, increased 13.29 % YoY.

IDEXX Laboratories Inc. EPS for the last quarter amounts to 3.40 USD, increased 21.43 % YoY.

IDEXX Laboratories Inc (IDXX) has 11000 emplpoyees as of January 10 2026.

Today IDXX has the market capitalization of 56.96B USD.